Shares of Tel Aviv-based InspireMD plunged 30% during morning trade after the company priced its public offering of 486,957 common stock at $5 apiece. The company, which makes Carotid Embolic Prevention System, expects $2.4 million in net proceeds from the offering, which will close on April 8, 2019.
The company has lost 86% of its value in the trailing 52 weeks. For the year-to-date period, the stock is down 12%.
Meanwhile, ReWalk Robotics stock slipped 3% during the pre-market hours after the prosthetics firm said it would offer about 816,914 ordinary shares at a purchase price of $5.2025 apiece in a registered direct offering.
ReWalk will also issue unregistered warrants to buy about 408,457 ordinary shares, with a term of 5.5 years and exercise price of $5.14 per ordinary share.
The company, which makes wearable robotic exoskeletons for individuals with lower limb disabilities, expects gross proceeds of approximately $4.25 million. The offering is expected to close on April 8.
The stock is down 80% in the trailing 52 weeks. For the year-to-date period, the stock is up 6.2%.
The pandemic-induced financial uncertainties have changed the dynamics of the consumer lending market. Customers are being drawn to online lending platforms that provide easy access to credit on convenient terms
While bitcoin and other digital currencies have seen a fair share of ups and downs so far this year, investor interest in cryptocurrency has grown undeniably during this period. The
Software giant Oracle Corporation (NYSE: ORCL) reported a 28% growth in fourth-quarter earnings, aided by an increase in revenues. The results also topped Wall Street's prediction. At $11.2 billion, revenues